期刊文献+

胸腺瘤组织COX-2和podoplanin表达及其临床意义的研究

Expressions and clinical significance of COX-2 and podoplanin in thymoma tissues
下载PDF
导出
摘要 目的探讨环氧化酶-2(cox-2)、平足蛋白(podoplanin)在胸腺瘤组织中表达的生物学、临床意义及其相互关系。方法采用免疫组织化学SP(streptavidin-perosidase)法,检测51例胸腺瘤患者中COX-2、podoplanin的表达。结果 51例胸腺瘤组织中,随着Masaoka分期进展,COX-2、podoplanin阳性表达率逐渐升高,差异有统计学意义,X2值分别为28.00和23.64,P值分别<0.05。COX-2和podoplanin的阳性表达率与胸腺瘤的Masaoka分期等参数有关;与胸腺瘤组织学分型有关,X2值分别为11.79和25.27,P值分别为0.007和0.021,P>0.05。A/AB型胸腺瘤COX-2阳性率与B1-3型胸腺瘤比较有统计学意义(P<0.05)。COX-2与podoplanin的表达呈正相关,r=0.569,P<0.01.认为COX-2和podoplanin的阳性表达与胸腺瘤是否合并重症肌无力(MG,Myasthenia Gravis)无关,X2值分别为0.370和0.004,P值分别>0.05。结论 COX-2及podoplanin的表达与胸腺瘤的发生及侵润性相关,可作为其判断临床生物学行为和恶性程度的重要生物学指标,为临床医生提供诊断和辅助治疗依据。 【Objective】 To investigate the biological 、clinincal significance and relationship between COX-2 and podoplanin expressions in thymoma.【Methods】 The expression of COX-2 and podoplanin were detected and compared by using immunohistochemical technique among 51 thymomas.【Results】 The expressions of COX-2 and podoplanin significancly increased along with the advance of thymoma Masaoka stage(X2 were 28.00 and 23.64,P0.05),and there is relevance with the thymoma histology(X2 were11.79 and 25.27,P0.05).The positive rate of COX-2 of type A/AB thymomas was significantly lower than that of type B1-3.There was a significance relationship between the expressions of COX-2 and podoplanin(P0.05).The expressions of COX-2 and podoplanin had a positive correlation(r=0.569,P 0.01).The expression of COX-2 of thymoma had no obvious correlation with MG(X2 were 0.370 and 0.004,P0.05).【Conclusion】 COX-2 and podoplanin expressions are positive correlation with advance of Masaoka stage.The increasing expressions of COX-2 and podoplanin can be a important biological parameters to maligiancy and biological behavior for thymoma,and can be provided the evidence for diagnosis and adjunctive therapy.
作者 孙鹏飞 陈秀
出处 《中国医学工程》 2011年第8期45-47,56,共4页 China Medical Engineering
关键词 胸腺肿瘤 病理学 环氧化酶 平足蛋白 重症肌无力 thymoma pathology COX-2 podoplanin MG
  • 相关文献

参考文献18

  • 1Kanzaki M, Oyama K, Ikeda T, et al. Noninvasive thymoma in the middlemediastinum[ J]. Ann Thorac Surg, 2004,77 ( 6 ) : 2209 - 2210,.
  • 2Travis WD, Brambilla E, Muller - Hermelink HK,et al. Pathology and genetics of tumors of the lung, pleura, thymus and heart. World Health Organization classification of tumours [ J ]. Lyon: IARC Press ,2004.
  • 3Gamboa EO, Sawhney V, Lanoy RS, et al. Widespread metastases after resection of noninvasive thymoma[ J]. J Clin Onco1,2008,26 : 1752 - 1755.
  • 4Alexiev BA, Drachenberg CB, Allen AP, et al. Thymomas: a cy- tologic and immunohistochemical study, with emphasis on Lymphoid and neuroendocrine markers [ J ]. Diagn Pathol 2007,2 : 1746 - 1796.
  • 5Stein JP, Grossfeld G, Ginsberg D, et al. Prognostic markers in blad- der cancer: a contemporary review of the literature [ J].J Urol, 1998,160:645 - 659.
  • 6Skomedal H, Kristensen GB, Lie AK, et al. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cy- clin D1, RB, and EGFR in cervical carcinomas [ J ]. Gynecol On- col, 1999,73 (2) :223 - 228.
  • 7Williams CS. Prostaglandin endoperoxide synthase: why two iso- forms? [J]. Am J hysiol,1996,270(3Pt1) :G393 -400.
  • 8Larkins T L, Nowell M, Singh S, et al. Inhibition of eyclooxygenase -2 decreases breast cancer cell motility, invasion and matrix met- alloproteinase expression [ J ]. BMC Cancer, 2006, 10 ( 6 ) : 181 - 192.
  • 9Liu J, Yu HG, Yu JP, et al. Overexpression of Cyclooxygenase - 2 in gastric cancer correlates with the high abundance of vaseular endothelial growth factor - c and lymphatic metastasis [ J ]. Med Oncol,2005,22 (4) :389 - 397.
  • 10Pai RSoreghan B, SzabO IL. ProstagLandin E2 transactivates EGF receptor:A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy [ J ].Nat Med,2002,8 ( 3 ) :289 - 293.

二级参考文献21

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部